Not checkedNot checked for notices yet.
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity
Mubeen M. Mosaheb, Elena Y. Dobrikova, Michael C. Brown and 7 more
Nature Communications · 2020
doi:10.1038/s41467-019-13939-z (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Experimental PVSRIPO oncolytic virus therapy of glioblastoma has shown long-term efficacy in a subset of patients. Here the authors engineer the virus to enable incorporation of tumor-specific antigens, and show proof-of-principle evidence that this modification increases anti-tumor immunity and extends survival in mice.
Abstract licence: CC BY-NC-ND
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.